Navigation Links
Curemark Appoints Preeminent Pediatrics Gastroenterologist

RYE, N.Y., Dec. 18 /PRNewswire/ -- Curemark's Board of Directors announced today that Steven M. Schwarz, MD, FAAP, FACN, AGAF, will join the company as a senior scientist and will serve on the company's Scientific Advisory Board. Dr. Schwarz is presently Chairman of the Department of Pediatrics at The Long Island College Hospital and Professor of Pediatrics at the State University of New York Health Science Center at Brooklyn.

"Dr. Schwartz is one of America's foremost authorities on pediatric gastroenterology," states Dr. Joan Fallon, Curemark's CEO. "Having Dr. Schwarz as an integral part of Curemark will assist the company greatly as we prepare for autism clinical trials scheduled for the early part of 2008. His vast expertise in the areas of gastroenterology and developmental disabilities is a perfect fit with Curemark's research and proprietary work in pediatric dysautonomia, autism and ADHD."

A graduate of Yale College and Columbia University's College of Physicians and Surgeons, Dr. Schwarz received his training in Pediatrics and Pediatric Gastroenterology and Nutrition at Columbia and Stanford Universities. Dr. Schwarz served on the faculty of the Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine from 1980-84, and at New York Medical College from 1984-95. At New York Medical College, he was awarded the Charles H. Revson Foundation Career Scientist Award. In 1995 he was named Distinguished Lecturer in the Graduate School of Health Sciences.

Curemark, with offices in Rye, NY, is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in autistic children. She has identified and patented a series of biomarkers that delineate which autistic patients may have digestive deficiencies underlying their disease. Curemark is the first company to deliver upon the connection between a variety of conditions, including autism, ADD/ADHD, Parkinson's and others that have roots in the gastrointestinal tract. To learn more about our innovative science, visit

Media Contact:

Kate Taylor


Investment Contact:

Ken Nanus


This release was issued through eReleases(TM). For more information, visit

SOURCE Curemark
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
Post Your Comments:
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... , ... Khanna Vision Institute based in Los Angeles, announced that Dr. Khanna ... Peer Certification by the Board is done so the public knows that the Doctor ... after the completion of three years of training or Residency in Ophthalmology. This is ...
(Date:11/29/2015)... Aliso Viejo, CA (PRWEB) , ... November 29, ... ... is an all new and unique analog distortion effect tool designed specially for ... to their footage, and create limiltess looks with the easy-to-use modification controls. Destoying ...
(Date:11/28/2015)... ... November 28, 2015 , ... ... services, has added Chris Hafey and Claude Hooton to its board of directors. ... of North America (RSNA) 2015 Annual Meeting and continues to strategically transform its ...
(Date:11/28/2015)... ... ... 30th at 6:00 a.m. EST until 11:59 p.m. EST, customers will be ... 20% off orders $80 or more to free gifts with purchases, there will be a ... competitive e-commerce website for skin care and cosmetic needs, customers will save on already discounted ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... the recent 2015 American Dental Association meeting in Washington D.C. revolved around the fact ... a patient’s overall health. The talk stressed the link between periodontal disease (more commonly ...
Breaking Medicine News(10 mins):